Navellier & Associates Inc. raised its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,660 shares of the medical research company’s stock after purchasing an additional 904 shares during the […]